Searched for
INDIA COVID CASES
Reliance AGM 2026 Key Highlights: From Jio IPO, AI ventures to retail bets, check key announcements by Mukesh AmbaniRIL AGM 2026 Key Highlights: Reliance Industries Chairman Mukesh Ambani unveiled major plans at the company's annual general meeting. Key a...- Tulsi Gabbard alleges Anthony Fauci funded Wuhan research in China that sparked COVID-19Outgoing US Director of National Intelligence Tulsi Gabbard has released declassified documents. These documents accuse Dr. Anthony Fauci o...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 27%As the market seems to be in comeback mode, it helps to be aware that the best (and probably biggest) wealth creator of the last couple of ...
- ET Alpha Wealth Summit | Quality has rarely been this cheap relative to junk; 3 themes to buy now: Saurabh MukherjeaQuality stocks in India and globally are at their cheapest in years. Saurabh Mukherjea highlights export-oriented manufacturing, European a...
- Don't wait for FIIs: Nippon MF CIO Sailesh Raj Bhan on why market will rise before foreign money returnsIndian equities offer rare discounts for investors. Nippon India Mutual Fund's Equity CIO, Sailesh Raj Bhan, advises accumulating world-cla...
- No Covid, yet Rs 3.71 lakh hospital bill: Gujarat man's insurance paid only Rs 1.78 lakh, deducting Rs 1.64 lakh; Then court delivered justiceA Gujarat consumer commission ordered a hospital and doctor to refund Rs 1.64 lakh to a patient. The patient was wrongly billed under a Cov...
- Technology and liquidity are reshaping India's investment landscape: Kailash KulkarniIndia's mutual fund sector is transforming. Technology and investor awareness of liquidity are key drivers. The pandemic highlighted the ea...
- Fable 5 shock puts sovereign AI back on India’s agendaUS export controls on advanced AI models have spurred India's call for sovereign AI development. Industry leaders warn against reliance on ...
- DBS optimistic about India’s long-term structural growth: Chief says country must invest in talent; focus on wealth spaceDBS Bank's CEO views India as a significant long-term growth opportunity. The nation can benefit from the AI-driven demand for hardware. Ho...
- Unauthorised absence by RBI official grave misconduct: Bombay HC; upholds his removalThe Bombay High Court has ruled that an Reserve Bank of India official's unauthorized absence from work is grave misconduct. The court dism...
- 12 years of PM Modi: Bold reforms, decisive decisions and political turning pointsAfter 12 years at the helm, Prime Minister Narendra Modi reflects on a transformative journey filled with key reforms that have altered Ind...
- Six months on, National Sports Awards still await nodIndia's sporting community faces an unusual delay in the National Sports Awards. The Sports Ministry cites a re-evaluation of Arjuna awarde...
- West Asia crisis: Why India needs a fertiliser security strategyIndia’s fertiliser security is deeply tied to global supply chains. The country imports 60% of its DAP requirement, remains fully dependent...
- AI threat overblown: Why Invesco’s Hiten Jain is doubling down on IT stocksInvesco Mutual Fund's Hiten Jain offers a contrarian view, identifying the tech rout as a significant buying opportunity and dismissing bro...
- ET Alpha Wealth Summit: Rajeev Thakkar of PPFAS MF explains when to hold, when to exit, and why most investors get it wrongPPFAS CIO Rajiv Thakkar said successful investing depends more on patience than frequent trading. He advised avoiding unnecessary selling, ...
- MSMEs to bear bigger hit than large firms from West Asia conflict: CrisilThe ongoing crisis in West Asia has struck a harsh chord for Indian small enterprises, leaving them vulnerable to significant setbacks. Ant...
- Serum Institute of India to manufacture Oxford Ebola vaccine backed by $8.6 million CEPI fundingSerum Institute of India will produce clinical trial doses of a new Ebola vaccine from Oxford University. This initiative is backed by fres...
- Moderna and other groups get $60 million to develop Ebola vaccineCEPI is investing around $60 million to speed up the creation of vaccines against the deadly Ebola Bundibugyo virus. This funding will supp...
- What to know about the outbreak of a rare kind of Ebola as cases outpace responseA rare Ebola outbreak is spreading rapidly in Congo and Uganda. The Bundibugyo virus has no approved treatments. Health workers face challe...
- Wockhardt secures US FDA approval for antibiotic ZaynichWockhardt's novel antibiotic, Zaynich (cefepime and zidebactam), has received US FDA approval for complicated urinary tract infections. Thi...
Load More
